ROCHE TO RESUME RECRUITMENT FOR AVANT DRUG TRIALS

A A

Swiss pharmaceutical company Roche Holding AG (RHHBY) Tuesday said it wants to resume patient recruitment into the AVANT trial. The AVANT trial tests different combination chemotherapies, including its two drugs Xeloda and Avastin, for post-surgical adjuvant treatment of colon cancer.

MarketWatch (http://www.marketwatch.com/News/Story/Story.aspx?dist=newsfinder&siteid=google&guid=%7BD1B95734-38F4-4E03-99C5-0C29B124C34E%7D&keyword=)